Filter
2761
Filtered Results: 2761
Text search:
CDC
Centers
for
Disease
Control
and
Prevention
Featured
Recommendations
283
New Publications
694
Language
Document type
No document type
1435
Guidelines
420
Studies & Reports
277
Fact sheets
177
Manuals
133
Strategic & Response Plan
91
Training Material
59
Resource Platforms
58
Infographics
57
Situation Updates
23
Brochures
19
Videos
7
Online Courses
3
Dashboards/Maps
2
Countries / Regions
Global
132
Africa
117
Sierra Leone
98
Liberia
90
West and Central Africa
86
Ethiopia
73
Nigeria
70
East and Southern Africa
65
Middle East and North Africa
64
Kenya
63
India
62
Guinea
56
Senegal
51
Congo, Democratic Republic of
49
Mozambique
47
Uganda
45
Ghana
40
Rwanda
39
Haiti
38
Zambia
36
Burkina Faso
35
Guinea-Bissau
34
Tanzania
34
Latin America and the Carribbean
34
South Africa
33
Malawi
33
Namibia
31
Western and Central Europe
31
South Sudan
30
Angola
29
Côte d’Ivoire / Ivory Coast
28
Mali
26
Germany
26
Bangladesh
25
Syria
24
Russia
24
Brazil
23
Yemen
23
Cameroon
20
Zimbabwe
20
Nepal
18
USA
16
Niger
16
Chad
16
Madagascar
16
Cambodia
15
Colombia
15
Ukraine
14
Eastern Europe
14
Indonesia
12
Asia
12
Philippines
10
Botswana
10
Vietnam
9
Eswatini/ Swaziland
8
Lesotho
8
Paraguay
8
Pakistan
6
Ecuador
6
Myanmar / Burma
6
South–East Asia Region
6
Eastern Europe and Central Asia
6
Egypt
5
Benin
5
Venezuela
5
Spain
5
Togo
4
Central African Republic
4
North America
4
France
4
Portugal
4
Saudi Arabia
3
Somalia
3
Afghanistan
3
Thailand
3
China
3
Peru
3
Bolivia
3
Laos
3
Iraq
2
Lebanon
2
Turkey
2
Gambia
2
Sudan
2
Argentina
2
Mexico
2
Chile
2
Western Pacific Region
2
Congo-Brazzaville
2
Tunisia
2
Morocco
1
Jordan
1
Malaysia
1
Dominican Republic
1
Burundi
1
Honduras
1
Cape Verde
1
Sri Lanka
1
Bhutan
1
Palestine
1
Italy
1
Albania
1
Djibouti
1
Armenia
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Gabon
1
Uruguay
1
Japan
1
Belgium
1
Mauritius
1
United Kingdom
1
South Korea
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
1004
Clinical Guidelines
224
Public Health
139
Key Resources
127
Women & Child Health
78
Pharmacy & Technologies
44
Capacity Building
41
Toolboxes
COVID-19
501
Ebola
232
HIV
208
TB
189
Rapid Response
158
AMR
132
NTDs
104
Zika
83
NCDs
70
Mental Health
59
Caregiver
47
Planetary Health
47
Cholera
45
Refugee
43
Specific Hazards
31
Polio
28
Natural Hazards
25
Pharmacy
25
Global Health Education
17
Disability
16
Conflict
11
Health Financing Toolbox
11
Social Ethics
1
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of em...
To guide One Health capacity building efforts in the Republic of Guinea in the wake of the 2014–2016 Ebola virus disease (EVD) outbreak, we sought to identify and assess the existing systems ... structures for zoonotic disease detection and control. We partnered with the government ministries responsible for human, animal, and environmental health to identify a list of zoonotic diseases – rabies, anthrax, brucellosis, viral hemorrhagic fevers, trypanosomiasis and highly pathogenic avian influenza – as the country's top priorities. We used each priority disease as a case study to identify existing processes for prevention, surveillance, diagnosis, laboratory confirmation, reporting and response across the three ministries. Results were used to produce disease-specific systems “maps” emphasizing linkages across the systems, as well as opportunities for improvement. We identified brucellosis as a particularly neglected condition. Past efforts to build avian influenza capabilities, which had degraded substantially in less than a decade, highlighted the challenge of sustainability. We observed a keen interest across sectors to reinvigorate national rabies control, and given the regional and global support for One Health approaches to rabies elimination, rabies could serve as an ideal disease to test incipient One Health coordination mechanisms and procedures. Overall, we identified five major categories of gaps and challenges: (1) Coordination; (2) Training; (3) Infrastructure; (4) Public Awareness; and (5) Research. We developed and prioritized recommendations to address the gaps, estimated the level of resource investment needed, and estimated a timeline for implementation. These prioritized recommendations can be used by the Government of Guinea to plan strategically for future One Health efforts, ideally under the auspices of the national One Health Platform. This work demonstrates an effective methodology for mapping systems and structures for zoonotic diseases, and the benefit of conducting a baseline review of systemic capabilities prior to embarking on capacity building efforts.
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality ... morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IPC) is a key pillar in the outbreak response; adherence to IPC practices can prevent and control transmission of infections to health and care workers, patients and their family members.
During the 2014-2016 West African Ebola disease outbreak, there was an urgent need for rapid IPC guidance to help support ministries of health, health-care providers and non-governmental organizations (NGOs). In response, WHO produced several documents related to the outbreak based on expert opinion, including IPC-specific documents and documents on clinical management that also referenced key IPC principles and practices. Since that time, many practices in the field have become institutionalized.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.6% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention...
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to d...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.9% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
Key stakeholders must be involved in the planning, implementation, monitoring and evaluation of NCD plans and programmes. Within a ministry of health there will be different types of stakeholders, s...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness ... infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-19 in healthcare settings, including long-term care facilities (LTCFs). In addition, this document addresses the management of clinical diagnostic specimens at laboratories in the EU/EEA. This is the sixth update of the ECDC guidance on ‘Infection prevention and control and preparedness for COVID-19 in healthcare settings’, and replaces the document dated 6 October 2020.
Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
The NCD Alliance website provides information and resources on preventing and controlling non-communicable ... (NCDs), including cardiovascular diseases, cancer, respiratory diseases, diabetes, and mental health conditions. The Alliance advocates for global health policies, supports countries in integrating NCD care into universal health coverage, and fosters collaboration among governments, civil society, and health organizations. Key sections include policy briefs, advocacy priorities, research reports, and campaigns aimed at reducing NCD-related health disparities and improving health outcomes worldwide. The site serves as a hub for NCD advocacy, awareness, and community engagement.
The prevalance of asthma an allergy, defined as immunologically mediated hypersensitivity, is increasing. It is estimated that over 20% of the world population suffers from IgE-mediated allergic disease, such as allergic asthma, allergic rhinitis ... allergic conjunctivitis, atopic eczema/atopic dermatitis, and anaphylaxis. Asthma, which in more than 50% of adults and in at least 80% of affected children is allergic, occurs in around 5-15% in the paediatric population. Asthma it estimated by the World Health Organization (WHO) to affect about 150 million people worldwide, placing an enormous strain on health resources in many countries, and is a major cause of hospitalizations for chronic diseases in children in the western wolrd.
Information may be derived from areas where a rapid increase in disease has occured, to from the basis for prevention strategies in areas where the prevalence of these diseases is still low. Where current expert opinion is still divided, where future research is required, or studies have provided negative results, the available information may prevent the implementation of unnecessary, restrictive, and costly avoidance strategies.
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and ... for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infrastructure, are key components for containment and mitigation of the impact of pathogens that may constitute a major public health threat. In these guidelines, the options of using natural ventilation and/or exhaust fan assisted ventilation in health-care facilities (HCF) are considered.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations ... community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.
The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox
